skip to main content

    Updated Visitor Guidelines

 

MENU

 

62% of colorectal cancer patients report financial burden from treatment, study finds

Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Rogel Cancer Center. The burden was greatest among patients who received chemotherapy.

A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

Protocol

UMCC 2013.019

Purpose

The purpose of this study is to evaluate the efficacy and safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly diagnosed mantle cell lymphoma.

UMCC Site Principal Investigator

Thyroid cancer genome analysis finds markers of aggressive tumors

A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.

U-M head and neck cancer surgeon elected to prestigious Institute of Medicine

From the University of Michigan Rogel Cancer Center, head and neck surgeon Carol R. Bradford, M.D., chair of otolaryngology-head and neck surgery, was elected to the Institute of Medicine in recognition of her major contributions to the advancement of the medical sciences, health care and public health.

Prostate Cancer Team

The University of Michigan Rogel Cancer Center is provides a comprehensive, team approach to cancer specialty care. Although a patient may not see each member of the team, all of the specialists listed below are involved in reviewing patients’ cases and recommending a treatment plan that is tailored to the each patient.

Penile Cancer Team

Your University of Michigan Specialists:

Surgical Urology

Radiation Oncology

Medical Oncology

Pages